SCHEMBL29567367

SCHEMBL29567367

CCc1c(Cl)nc(NS(=O)(=O)c2cnn(C)c2)nc1Oc1cccc(N2CCN(C)CC2)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 11/20 0.35
▸ HTR1A P08908 5/20 0.35
▸ HTR2A P28223 3/20 0.35
▸ DRD2 P14416 2/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ BRPF1 P55201 1/20 0.34
▸ BRD9 Q9H8M2 1/20 0.34
▸ HTR7 P34969 4/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ EGFR P00533 1/20 0.32
▸ INSR P06213 1/20 0.32
▸ MET P08581 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310029 1.00 HTR6 (0.35) HTR6HTR1AHTR2ADRD2DRD4
SCHEMBL24309483 0.92 HTR1A (0.41) HTR6HTR1AHTR2ADRD2DRD4
SCHEMBL29566556 0.92 HTR1A (0.41) HTR6HTR1AHTR2ADRD2DRD4
SCHEMBL29566934 0.84 HTR7 (0.39) HTR6HTR1AHTR2ADRD2HTR2C
SCHEMBL24310020 0.84 HTR7 (0.39) HTR6HTR1AHTR2ADRD2HTR2C
SCHEMBL24309320 0.83 HCRTR1 (0.35) HTR6HTR1AHTR2ADRD2DRD4
SCHEMBL29566767 0.83 HCRTR1 (0.35) HTR6HTR1AHTR2ADRD2DRD4
SCHEMBL24310358 0.83 BRD9 (0.36) HTR6HTR1AHTR2ADRD2DRD4
SCHEMBL24310629 0.83 HTR1A (0.36) HTR6HTR1AHTR2ADRD2KMT2A
SCHEMBL29566939 0.83 BRD9 (0.36) HTR6HTR1AHTR2ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback